Humane Research Trust trustee.
Successful utility industry senior leader, now retired, keen to apply that experience volunteering in charities, trusts and education.
😳 "Why Boston? Why on Earth would you start your new laboratory there and not, say, Brno? You could have saved yourselves quite an effort!"
To answer this question in the manner it deserves, we’re embarking on a small series. First, we'll offer a few science-related facts; later, we'll share fun historical tidbits. (And there are plenty.)
✌ Boston and Cambridge form a biotechnology hub with over 1,000 biotech companies.
✌ The area boasts more than 50 colleges and universities.
✌ For years, Boston has ranked #1 in the US for NIH funding, recently receiving over $2.7 billion annually for cutting-edge research.
✌ In 2024, the top three NIH award-earners were the UMass Chan Medical School, Harvard Medical School and Boston University Medical Campus. Together, they amassed $409 million. (Source: NIH)
In other words, if you break a leg in Boston, there’s a fair chance a great specialist will attend to you. On a more serious note, context is everything. In literature as well as in science.
That's why IOCB Prague - Institute of Organic Chemistry and Biochemistry of the Czech Academy of Sciences is going global.
#WeMadeIt#PragueMeetsBoston
Puerto Rico is advancing as a central hub in the life sciences and biotech sectors, with significant developments at the Puerto Rico Molecular Science Research Center. This includes the creation of three innovative research facilities designed to propel the island as a hub for scientific research, development, and entrepreneurship. These centers are set to revolutionize Puerto Rico's capacity in these fields, aligning with global scientific advancements and local economic growth. 🚀🧪
At DECA Analytics, we're excited about this development, as it aligns perfectly with our mission to support strategic investments and compliance in Puerto Rico. Our expertise is crucial in aiding businesses and research entities to navigate and maximize these expanding opportunities, reinforcing Puerto Rico's position on the global stage of scientific innovation and economic development. 💡🌍
#LifeSciencesPuertoRico#DECAAnalytics#BiotechInnovation#ScientificResearch#EconomicGrowth
Senior Vice President at Novo Nordisk Foundation - Societal Impact: Evaluation, Analysis, Data, Return on Investment, Theory of Change, Science of Science, Economics of Innovation and Science, Research, Impact Management
41 exceptional Nordic researchers have just received a Novo Nordisk Foundation career grant (for at total amount of EUR 57.3 million). The researchers work across a broad spectrum of scientific disciplines.
The recipients represent a diverse range of institutions from all the Nordic countries, including for instance Aalborg University Hospital, Syddansk Universitet - University of Southern Denmark, Karolinska Institutet Institute, University of Helsinki, Danish Cancer Society and Københavns Universitet - University of Copenhagen.
The Novo Nordisk Foundation Research Leader Programme aims to support researchers at various stages of their careers, providing them with the necessary resources to conduct groundbreaking research. Since 2018, more than 240 researchers have received grants for a total of nearly EUR 400 million.
The 2024-grants cover five key research areas:
- Endocrinology and Metabolism Research: 10 grants.
- Clinical and Translational Research: 10 grants.
- Bioscience and Basic Biomedical Research: 13 grants.
- Plant Science, Agriculture and Food Biotechnology: 4 grants.
- Industrial Biotechnology and Environmental Biotechnology: 4 grants.
Our programme offers grants tailored to different career stages:
- Emerging Investigator: For researchers establishing their research groups.
- Ascending Investigator: For associate professors consolidating their research profiles.
- Distinguished Investigator: For internationally recognised professors.
Read more about each of this year’s grant recipients as well as previous years’ recipients at the Research Leader Programme website: https://lnkd.in/d9pCxptg.
Read more about the impact of the Novo Nordisk Foundation's support to science in our new annual impact report:
https://lnkd.in/dDjx9qzP
ITHS Pilot Program Awards: Apply Now!
**Letters of Intent due on July 9, 2024**
The ITHS Pilot Award Program is designed to help investigators with one of the biggest challenges they face: where to get funding for new projects. ITHS is offering funding to support researchers in translational science—the area of health research that focuses on speeding discoveries from lab to patient—as they take the first steps along the path of discovery. Read on to learn about the specific funding mechanisms.
https://buff.ly/45tDYw6
If you guys are in Europe (and even if not) there’s one of the best longevity events coming up May 15-19 in Spain. Longevity Biotech Fellowship (LBF) is running their 4th cohort initiation camp which is then followed up by an online program. Apply here: https://lnkd.in/eBdkzS3R
LBF is now focused on their own roadmap of research: bioengineering, biostasis (cryonics) and tissue/organ replacement. Catering and workouts are provided but not a single talk will be wasted on lifestyle interventions. The guys are longevity maximalists so only powerful enough approaches will be discussed. It’s a good platform to find like-minded people, co-founders and advisers.
Can’t recommend this fellowship enough: apply and spread the word!
The Clinical and Translational Science (CTS) Pilot Award aims to support new and innovative research projects relevant to #CTS. Letters of Intent are due 8/12 and we're offering an informational webinar 7/17 at 1 p.m. EST. Office hours are available for personalized feedback.
CTS is a field of investigation focused on understanding a scientific or operational principle that underlies a step of the translational process, with the goal of developing generalizable principles to accelerate translational research.
We encourage applications that propose addressing a common cause of inefficiency or failure in research projects at any stage of translation, with the goal of producing foundational knowledge that will ultimately improve health.
🔬 Discover AIMMS: VU Amsterdam's Molecular Research Accelerator.
The Amsterdam Institute for Molecular and Life Sciences (AIMMS) is a dynamic interdisciplinary research institute at VU Amsterdam. Founded in 2010, AIMMS brings together top researchers from various departments, including:
→ Scheikunde en Farmaceutische Wetenschappen VU
→ A-Life
→ Bio-informatics
💡 Our expertise
We are united in our molecular perspective in the fields of:
→ Food: from metabolism to fermentation, we delve into human health and food-related research.
→ Pharma: our work includes novel antimicrobials, vaccines, drug target research, and drug discovery.
→ Environmental & Life Science: we investigate environmental effects on human health, conduct assessments, and promote sustainability.
With our cutting-edge facilities and collaborative interdisciplinary teams:
→ We design and make molecules
→ We measure and monitor molecules
→ We understand and control molecules and their interactions
🤝 Partner in scientific breakthroughs
AIMMS is more than your regular research institute; we create incentive-based research to tackle societal challenges by fostering multi-disciplinary collaborations between scientists and private partners. Whether through hackathons, prize challenges, or dedicated research projects, we’re committed to creating a better future.
🎥 Discover how to work with AIMMS: https://lnkd.in/dQPuheus
📨 Stay updated: Subscribe to our newsletter for the latest news: https://lnkd.in/d6ErvJVC
The day before something becomes a breakthrough it is a crazy idea. Join us.
Bas Teusink#Research#Innovation#VUAmsterdam#AIMMS#ScientificDiscovery
Stimulator Grants open till April 26, 2024 to support regional collaborations, national networks and international visibility.
This call is for Alliance members only!
The seed funding is for newly established joint research projects at Alliance Institutions.
• Innovative interinstitutional projects, transfer/translation projects as well as interdisciplinary projects (e.g., between the life sciences/biomedicine and the social sciences/humanities)
• Grants as drivers of innovative projects and the basis for subsequent third-party funding
They are awarded in three categories with different aims:
• regional collaborations
• national networks and
• international visibility.
https://lnkd.in/exVEqnPS#innovation#interinstitutional#international
Fantastic insights from Dr. Lívia Santos! Perseverance in funding bids is truly an art.